tirzepatide or semaglutide which is better vs for Weight Loss Tirzepatide GLP-1 medication may be

Food and Drug Administration (FDA) has warned against the use of GLP-1 RA by individuals with personal or family history of medullary thyroid cancer and hereditary conditions associated with this type of cancer. With this in mind, investigators evaluated whether people with type 2 diabetes who take GLP-1 RAs are at a higher risk of developing thyroid cancer compared with those taking other common diabetes medications

Diabetes is a Growing Epidemic There are nearly 30 million people in the United States with diabetes, with estimates of potentially growing to 50 million by 2030

Several states, including Pennsylvania, have actually tightened Medicaid GLP-1 coverage in 2026

Based on these measurements, the size of dissolved nanoparticle samples were relatively stable even after six months, but aggregation or disintegration cannot be excluded due to the large PDI values